Ascendis Pharma A/S (ASND) Stock Chart & Stock Price History $170.09 +3.51 (+2.11%) As of 03:21 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ascendis Pharma A/S Stock Price Performance 5 Day Performance+2.10%1 Month Performance+8.35%3 Month Performance+31.66%6 Month Performance+36.48%Year-To-Date Performance+21.74%1 Year Performance+21.06% Receive ASND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address ASND Stock Chart for Wednesday, April, 30, 2025 ASND Chart by TradingView Ascendis Pharma A/S Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$164.88$166.58+1.03%$168.96$165.00276,857 shs$10.16 billion04/28/2025$164.15$164.88+0.44%$167.37$161.61352,496 shs$10.05 billion04/25/2025$160.45$164.15+2.31%$167.29$157.66560,181 shs$10.01 billion04/24/2025$158.14$160.45+1.46%$161.02$155.54372,560 shs$9.78 billion04/23/2025$159.13$158.14-0.62%$161.87$155.96432,710 shs$9.64 billion04/22/2025$161.15$159.13-1.25%$163.47$153.171.18 million shs$9.70 billion04/21/2025$165.05$161.15-2.36%$165.28$156.07691,086 shs$9.83 billion04/18/2025$165.05$165.05$165.42$155.65629,215 shs$10.06 billion04/17/2025$158.15$165.05+4.36%$165.42$155.65629,215 shs$10.06 billion04/16/2025$153.92$158.15+2.75%$159.56$152.07409,728 shs$9.64 billion Get the Latest News and Ratings for ASND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$155.50$153.92-1.02%$156.97$153.11255,010 shs$9.38 billion04/14/2025$150.99$155.50+2.99%$159.14$150.99438,747 shs$9.48 billion04/11/2025$143.33$150.99+5.34%$153.34$142.18426,300 shs$9.16 billion04/10/2025$137.84$143.33+3.98%$146.93$132.52704,362 shs$8.70 billion04/09/2025$137.41$137.84+0.31%$153.49$124.061.18 million shs$8.37 billion04/09/2025$137.41$137.84+0.31%$153.49$124.061.18 million shs$8.37 billion04/08/2025$140.14$137.41-1.95%$146.44$134.34523,553 shs$8.34 billion04/08/2025$140.14$137.41-1.95%$146.44$134.34523,553 shs$8.34 billion04/07/2025$142.67$140.14-1.77%$143.64$131.77871,190 shs$8.50 billion04/04/2025$150.09$142.67-4.94%$147.49$139.57576,851 shs$8.66 billion04/03/2025$152.15$150.09-1.35%$155.45$147.56514,466 shs$9.11 billion04/02/2025$151.43$152.15+0.48%$154.96$148.90494,277 shs$9.23 billion04/01/2025$155.86$151.43-2.84%$158.45$148.40655,858 shs$9.19 billion03/31/2025$154.68$155.86+0.76%$156.96$143.81531,961 shs$9.46 billion Related Companies ARGX Stock Chart BNTX Stock Chart ONC Stock Chart SMMT Stock Chart TEVA Stock Chart ITCI Stock Chart GMAB Stock Chart RDY Stock Chart MRNA Stock Chart VTRS Stock Chart Receive ASND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ASND) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredYou’re About to Lose Everything – Act Now or Regret It ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASND Stock Free ASND Stock Alerts